AD2P (also locally referred to as the “Plateforme de Criblage Marseille-Luminy” (PCML)) plays a significant role in the research field of antivirals against emerging viruses.

Indeed, the facility has developed and offers expertise in the screening of viral enzyme inhibitors, protein/protein interactions, clinical virus isolates, the supply of chemical libraries, as well as in the development of new technologies and drug design.